Yale New Haven Health has appointed Thomas Jackiewicz, currently president of the University of Chicago Health System, as its new CEO, effective February 1, 2027.
NEW HAVEN, CT (Nov. 16, 2026) – Yale New Haven Health (YNHH), a principal healthcare provider in Connecticut, has announced the appointment of Thomas “Tom” Jackiewicz as its new chief executive officer, set to take office on February 1, 2027. This significant leadership change follows the ousting of the previous CEO, highlighting a pivotal moment in the governance of one of the region’s most prominent healthcare systems.
Background on Leadership Transition
Jackiewicz’s appointment marks a strategic move by YNHH’s Board of Trustees to enhance the organization’s operational and clinical effectiveness. The decision comes less than five months after the board terminated the former CEO, indicating a clear intent to revitalize leadership and strategy within the organization. The decision was made following an extensive national search led by a nine-member trustee search committee, which sought a leader capable of navigating the complexities of healthcare management in a rapidly evolving landscape.
Jackiewicz is not new to the demands of leading significant healthcare institutions. Since 2020, he has served as the president of the University of Chicago Health System, where he has been instrumental in driving performance and enhancing clinical services. His previous roles include CEO of Keck Medicine of the University of Southern California from 2012 to 2020, and CEO of the University of California San Diego Health System from 2009 to 2011. His extensive experience in managing major academic health systems underscores his ability to address both operational challenges and strategic growth opportunities.
Expertise in Healthcare Management
Jack Callahan, chair of the Yale New Haven Health Board of Trustees, expressed confidence in Jackiewicz’s leadership capabilities. He stated, “Tom is a seasoned and innovative leader with a proven ability to help academic health systems grow, strengthen performance, and expand access to exceptional care.” Callahan further noted that Jackiewicz’s leadership style emphasizes understanding the unique needs of healthcare organizations and their markets, rather than employing a one-size-fits-all approach. This adaptability is anticipated to be crucial in addressing the specific challenges faced by YNHH, particularly in the areas of patient care and operational sustainability.
During his tenure at the University of Chicago Health System, Jackiewicz led initiatives that resulted in substantial financial growth, with operating revenue more than doubling and operating profit increasing sixfold. His commitment to health equity has been particularly noteworthy, with efforts aimed at enhancing healthcare services for underserved populations, especially in Chicago’s South Side. This focus resonates with YNHH’s mission of providing comprehensive care to the diverse communities it serves.
Innovative Strategies and Community Focus
Jackiewicz has also been recognized for implementing innovative enterprise-wide strategies that significantly improve patient access and operational capacity. Under his leadership, the University of Chicago Medical Center achieved a remarkable improvement in its Vizient ranking for access to care, moving from 34th place in 2020 to eighth place by 2026. Furthermore, he has pioneered the integration of advanced technologies, including artificial intelligence, to enhance patient experiences and streamline healthcare operations.
In his remarks about joining YNHH, Jackiewicz expressed his enthusiasm: “Yale New Haven Health has an extraordinary foundation as an academic health system, with tremendous clinical expertise, talented people, and an important responsibility to the communities it serves. I am excited by the opportunities ahead and honored to join the organization at such an important point in its evolution.” His commitment to collaboration with colleagues across YNHH, the Yale School of Medicine, and Yale University showcases his intent to build upon the institution’s legacy and drive forward its mission.
Recognizing Interim Leadership
The transition to Jackiewicz’s leadership comes after a period of stability under Pamela Sutton-Wallace, who served as acting CEO since June. Callahan acknowledged her exceptional service, highlighting that under her guidance, YNHH has continued to advance key strategic and operational priorities. These include significant improvements in quality and safety, enhanced financial performance, and preparations for the opening of the Adams Neurosciences Center, which is expected to be a pivotal development for the organization.
Jackiewicz’s appointment is being closely monitored by stakeholders and the healthcare community as YNHH prepares to embark on this new chapter. His extensive experience and proven track record in leading healthcare organizations will be critical as YNHH navigates the challenges of providing high-quality care in a post-pandemic environment, while also focusing on community health needs and the integration of innovative healthcare solutions.
As the healthcare landscape continues to evolve, Jackiewicz’s leadership will be essential in positioning YNHH for future success, ensuring that it remains a leader in academic health systems and a vital provider of care in Connecticut.



No Comment! Be the first one.